Patent ID: 11944597
Assignee: XWPHARMA LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A method of treating narcolepsy, excessive daytime sleepiness, cataplexy, excessive daytime sleepiness associated with narcolepsy, excessive daytime sleepiness associated with Parkinson's disease, excessive daytime sleepiness associated with multiple sclerosis, cataplexy associated with narcolepsy, fatigue, fatigue associated with Parkinson's diseases, fatigue associated with multiple sclerosis, or fibromyalgia in a patient comprising administering to a patient in need of said treatment a therapeutically effective amount of a pharmaceutical composition comprising:
an immediate release component, wherein the immediate release component comprises from 2 g to 7 g of 4-((L-valyl)oxy)butanoic acid; and
a modified release component, wherein the modified release component comprises from 7 g to 15 g of 4-((L-valyl)oxy)butanoic acid.